Network Updates, 22 August 2017
Welcome to our brief, weekly Network News Update. If you would prefer to receive the monthly eBulletin only, email firstname.lastname@example.org.
Log into TENx for complete details and RSVP information for all KF events, unless noted.
- August 22 (tonight), 6-9pm: SF Bay Area Chapter meeting at Mayfield
- September 1: Applications open for Class 23 (see KF website for details)
- September 8: Chicago Chapter breakfast; contact Karen Kerr or her assistant Ceil Espano for details or to RSVP
- September 14: KF Women’s Group breakfast. Hosted by Miriam Rivera (Class 15) at her private residence.
- September 22: NY Regional Chapter breakfast
- September 24 – November 13: Venture Deals online course (free)
- October 5: Defy Ventures visit to California State Prison – Solano
- October 22-27: Modules 2 & 5
Intercontinental Hotel, San Francisco
- December 8: NY Regional Chapter breakfast
- January 21-26, 2018: Modules 3 & 6
Convene, 101 Park Ave., NYC
- International Summit, April 22-27, 2018: Tel Aviv & Jerusalem, ISRAEL
- Jennifer Fried (Class 20) Quoted in Article on Medtech IoT Complexity
- Andras Forgacs (Class 14) Writes on the New Age of Biotech on World Economic Forum Website
- On the move: Adam Tomasi (Class 11) is now CFO and COO at Allakos
- Podcasts: Daniel Kraft (Class 13) on Dell Technology’s Perspectives / Trailblazers podcast
- Blogs: Derek Bittar (Class 19) • Jorge Torres (Class 16) • Samir Kaji (Class 20) • David Goldberg (Class 22) • Victoria Fram (Class 22)
- Job opportunities: (CONTINUING) Village Capital has numerous positions open, in Washington DC & Mexico City • Kauffman Foundation seeks a Senior Content Marketing Specialist
Jennifer Fried (Class 20) Quoted in Article on Medtech IoT Complexity
Jennifer Fried (Class 20), CEO and co-founder at ExplORer Surgical, was quoted in “What Is the Hardest Thing About Medtech IoT?” from Medical Design & Outsourcing. Medtech IoT marries two fields, each of which is complex on its own. Medical experts tend not to be familiar with the intricacies of the technology, and IoT specialists tend to lack familiarity with the complexities of healthcare. IoT “requires supply chain scalability all the way,” while healthcare is subject to more regulation than most fields—with the higher stakes as well. As Jennifer puts it: “There are tremendous challenges navigating all of the different stakeholders you have to work with to drive any type of change in this industry (the payers, the providers, the IT groups, the value analysis committees, the regulatory bodies…).”
Jennifer will also participate in the panel “Medtech Evolution: Talking IoT, data analytics, and data management” at DeviceTalks Boston on October 2. Panelists will discuss real-world lessons on collecting and managing data and analytics. The one-day conference offers “an exchange of ideas, insight and technology among the pioneers of the medical technology industry and the engineering behind it,” with networking receptions, in-depth interviews, and panel discussions to attend.
Andras Forgacs (Class 14) Writes on the New Age of Biotech on World Economic Forum Website
Andras Forgacs (Class 14), co-founder and CEO of Modern Meadow, wrote an article on the World Economic Forum’s website, “From Spider Silk Shoes to Algae Fuel, Welcome to the New Age of Biotech.” He draws a parallel between the computer industry’s development and the potential of the biotechnology industry: “Only when a technology becomes affordable and ubiquitous enough can it usually begin to solve some of the world’s most pressing problems.” Instead of reading and writing code in 0s and 1s, biotechnology reads and writes in DNA base pairs. Another parallel: the cost of creating basic components in both industries has dropped continually—in fact, the cost of DNA sequencing has dropped even more steeply than transistor density on an integrated circuit (as predicted by Moore’s Law).
After dropping from $100M in 2001 to $10M in 2007, the cost of sequencing an entire genome dropped to $1000 in 2014; during the same period, the cost of sequencing a single DNA nucleobase fell from $1 to less than $0.000001. This lower cost creates opportunity. While bioengineering efforts have so far largely revolved around producing familiar materials (leather, neckties, fuel) in new ways (cell culture, spider silk, algae), Andras sees the industry starting to move toward real innovation—creating “materials and products that … exhibit qualities that don’t yet exist in nature.” He cites one project that aims to design “a plant that changes colour in the presence of explosives,” as well as the goal of one food biofabrication company to create “new flavours altogether.”
On the move:
Adam Tomasi (Class 11) is now CFO and COO at Allakos. The San Carlos, CA-based firm is a clinical-stage company developing therapeutic antibodies to treat allergy, inflammation, tissue damage, and proliferative disorders. [Press release]
This week’s Fellow blogs:
- Derek Bittar (Class 19): “How to Become an Immortal Startup” and “Entrepreneurs, Take the Red Pill Now!” [in reference to The Matrix, where the red pill has one see the world for what it really is]
- Jorge M. Torres (Class 16) has published another issue of Venture Stack: Insights for Fund Entrepreneurs
- Samir Kaji (Class 20): “Mapping Out the Institutional Seed Universe”
- David Goldberg (Class 22): “The Ideal Investor Group Post-Seed Raise”
- Victoria Fram (Class 22): “Equity-Only Investing Hurts Both VCs and Startups”
- (CONTINUING) Village Capital has numerous open positions: Director of Business Development, Agriculture Practice Lead, and Director of Finance & Operations (Washington, D.C.); Intern (Mexico City). Read the full descriptions online.
- (CONTINUING) Kauffman Foundation seeks a Senior Content Marketing Specialst; full details online.
Do you have a news story to share? Please email us: email@example.com.